TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004
TCL Archive In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract January 5, 1979
TCL Archive FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer September 24, 1999
TCL Archive Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored December 10, 1982
TCL Archive Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer March 28, 2003
